ChatGPT: weekly briefing
25 Oct – 1 Nov 2026
Top stories
- Family sues OpenAI over ChatGPT advice in fatal epilepsy drug taper (Bloomberg Law, 27 Oct) — A family has sued OpenAI in California, alleging ChatGPT gave an epilepsy patient unlicensed advice to taper her anti-seizure medication, leading to her death. The complaint was filed in San Francisco Superior Court.
- Texas sues OpenAI and Sam Altman over ChatGPT safety claims (Insurance Journal, 27 Oct) — Texas Attorney General Ken Paxton has sued OpenAI and Sam Altman, alleging ChatGPT harmed Texans. His office seeks an injunction to block minors' access. OpenAI said it is committed to working with states on industry-wide policy.
- OpenAI tightens weapons information limits for teen ChatGPT users (Reuters, 30 Oct) — OpenAI said it is tightening limits on weapons-related information ChatGPT provides to teenagers as part of a violence-prevention push. Reuters reported the company is also introducing further safeguards for younger users.
- OpenAI cuts funding target by $10bn amid tech stock rout (Business Times, 31 Oct) — The Financial Times reported that OpenAI has cut its latest funding round target by $10bn to about $20bn, with its valuation falling to $1.25tn. The report links the change to an AI-driven sell-off in tech shares.
- Patched ChatGPT share-link flaw could hijack logged-in sessions (AI Weekly, 31 Oct) — Security firm Parameter said a malicious shared ChatGPT link could run code in the session of anyone who opened it, exposing private chats. OpenAI has patched the flaw after escalating its severity rating.
